Long-term follow-up of the West of Scotland Coronary Prevention Study.
Tsubokura
Masaharu
M
Kami
Masahiro
M
D000924:Anticholesteremic Agents / Q000627:therapeutic use; D003327:Coronary Disease / Q000517:prevention & control*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D006937:Hypercholesterolemia / Q000188:drug therapy*; D008223:Lymphoma / Q000139:chemically induced*; D017035:Pravastatin / Q000009:adverse effects / Q000627:therapeutic use*
D000924:Anticholesteremic Agents; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D017035:Pravastatin